CIDRAP-ASP Report – Outcomes Research & AMR: A Human-Centered Perspective on a Biosocial Problem
15 December 2023
In the third of a three-part series, CIDRAP-ASP provides a socioeconomic perspective on AMR outcomes and cost-effectiveness research, advocating for greater consideration of social sciences perspectives, regional diversity and heterogeneity, and systems-based thinking in addressing the societal impacts and costs of AMR.
Further reading: CIDRAP
Author(s): Francesca Chiara and Natalie Vestin
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!